New-Onset Lymphopenia Assessed during Routine Follow-up Is a Risk Factor for Relapse Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Diffuse Large B-Cell Lymphoma

Biology of Blood and Marrow Transplantation

Volumn 16, Issue 3, 2010, Pages 376-383

  Porrata, Luis F ^a   Inwards, David J ^a   Ansell, Stephen M ^a   Micallef, Ivana N ^a   Johnston, Patrick B ^a   Hogan, William J ^a   Markovic, Svetomir N ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER RELAPSE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTION; PROGNOSIS; RECURRENCE RISK; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LOGISTIC MODELS; LYMPHOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOPENIA; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 75749156156     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.10.029     Document Type: Article

References (17)

1. Lerner R.E., Thomas W., Defor T.E., Weisdorf D.J., and Burns L.J. The international prognostic index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission. Biol Blood Marrow Transplant 13 (2007) 486-492
2. Huisman C., de Weger R.A., de Vries L., Tilanus M.G.L., and Verdonck L.F. Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia. Bone Marrow Transplant 39 (2007) 285-291
3. Lawler M., McCann S.R., Marsh J.C.W., et al. Serial chimerism analysis indicate that mixed haematopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post-SCT for SAA. Br J Haematol 144 (2008) 933-945
4. Baron F., and Sandmaier B.M. Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. Leukemia 20 (2006) 1690-1700
5. Porrata L.F., and Markovic S.N. Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation. Clin Exp Med 4 (2004) 78-85
6. Porrata L.F. Clinical evidence of autologous graft versus tumor effect. Am J Immunol 5 (2009) 1-7
7. Cheson B.D., Pfistner B., Juweid M.E., et al. Revised response criteria for malignant lymphoma. J Clin Oncol 25 (2007) 579-586
8. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representation of old estimators. Stat Med 18 (1999) 695-706
9. Dignam J.J., and Kocherginsky M.N. Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol 26 (2008) 4027-4034
10. Ghosh D. Proportional hazards regression for cancer studies. Biometrics 64 (2008) 141-148
11. Porrata L.F. Host immunity and survival. Leukemia Lymphoma 49 (2008) 843-844
12. Behl D., Ristow K., Markovic S.N., et al. Absolute lymphocyte count predicts therapeutic efficacy of rituximab in follicular lymphomas. Br J Haematol 137 (2007) 409-415
13. Bensinger D.T. Optimization of peripheral blood stem cell collection. Curr Opin Hematol 2 (1995) 219-226
14. Phillip T., Guglielmi C., Hagenbeek A., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapse of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333 (1995) 1540-1545
15. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
16. Rosenwald A., Wright G., Chan W.C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med 346 (2002) 1937-1947
17. Costa L.J., Feldman A., Micallef I.N., et al. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation. Br J Haematol 142 (2008) 404-412